The pathogenic role of coronary microvascular dysfunction in the setting of other cardiac or systemic conditions
Systemic inflammation is related to coronary microvascular dysfunction in obese patients without obstructive coronary disease
Coronary Microvascular Dysfunction
Plasma concentration of serotonin is a novel biomarker for coronary microvascular dysfunction in patients with suspected angina and unobstructive coronary arteries.
